VIDA VENTURES GP III, L.L.C. purchased 333.33K shares of LB PHARMACEUTICALS INC on the open market
Open‑market purchase worth $5.00M. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/16/2025ACC: 0001193125-25-204935
10% Owner
Since Sep 2025
-12.45M
Net shares
Net seller
$5.00M
Total acquired
2
Open market trades
2B · 0S
6
Total transactions
882.24K acquired · 13.33M disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+547.65K
Price / share
—
Trade value
—
% of position
New position
9/12/2025
0.00→547.65K
Common Stock
Indirect
Shares
+1.26K
Price / share
—
Trade value
—
% of position
New position
9/12/2025
0.00→1.26K
Common Stock
Indirect
Shares
+332.57K
Price / share
$15.00
Trade value
$4.99M
% of position
60.7%
9/12/2025
547.65K→880.21K
Common Stock
Indirect
Shares
+767.00
Price / share
$15.00
Trade value
$11.51K
% of position
60.8%
9/12/2025
1.26K→2.03K
Total
Net shares
+882.24K
Net value
$5M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/12/2025 | C · Conversion | +547.65K | — | — | New position | 0.00 | 547.65K |
| Common Stock Indirect | 9/12/2025 | C · Conversion | +1.26K | — | — | New position | 0.00 | 1.26K |
| Common Stock Indirect | 9/12/2025 | P · Purchase | +332.57K | $15.00 | $4.99M | 60.7% | 547.65K | 880.21K |
| Common Stock Indirect | 9/12/2025 | P · Purchase | +767.00 | $15.00 | $11.51K | 60.8% | 1.26K | 2.03K |
| Total | +882.24K | $5M | ||||||
Derivative Transactions2
Series C Preferred Stock
Indirect
Converts to
Common Stock
547.65K shares
Shares
−13.30M
Strike price
Held after
0.00
Exercisable
—
9/12/2025
Series C Preferred Stock
Indirect
Converts to
Common Stock
1.26K shares
Shares
−30.67K
Strike price
Held after
0.00
Exercisable
—
9/12/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C Preferred Stock Indirect | Common Stock547.65K shares | 9/12/2025 | C · Conversion | −13.30M | — | 0.00 | |
| Series C Preferred Stock Indirect | Common Stock1.26K shares | 9/12/2025 | C · Conversion | −30.67K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.43K
Total
1.43K indirect1.43K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.43K | Indirect |
| Total | 1.43K | 1.43K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported